See the DrugPatentWatch profile for Norditropin
Norditropin 30mg is a high-dose formulation of somatropin, a recombinant human growth hormone. It is primarily used to treat growth failure in children and adults. The 30mg dosage is typically administered via a pen device for subcutaneous injection.
How is Norditropin 30mg Used?
Norditropin 30mg is prescribed for growth hormone deficiency in both pediatric and adult patients [1]. In children, it is used when they are not growing properly due to a lack of growth hormone [2]. For adults, it is used to treat growth hormone deficiency that began either in childhood or in adulthood [1]. The medication works by stimulating growth and cell reproduction [3].
What is the Difference Between Norditropin Cartridges and Pens?
Norditropin is available in various cartridges and pen devices that contain different amounts of somatropin. The 30mg formulation refers to the total amount of somatropin in a cartridge, which is designed to be used with a specific Norditropin pen device, such as the NordiFlex® pen [4]. The pens allow for precise dosing and are intended for self-administration by patients or caregivers.
When Can Norditropin Patents Expire?
The patent protection for pharmaceutical drugs like Norditropin plays a crucial role in market exclusivity. DrugPatentWatch.com tracks patent expiry dates, which can influence the availability of generic alternatives [5]. While specific patent expiry dates for Norditropin are subject to ongoing patent filings and legal challenges, information on such timelines is available through specialized patent tracking services [5].
Who Manufactures Norditropin?
Norditropin is manufactured by Novo Nordisk, a global healthcare company specializing in diabetes and other serious chronic diseases [1].
What Clinical Data Supports Norditropin's Use?
Clinical studies have demonstrated the efficacy of Norditropin in improving growth velocity in children with growth hormone deficiency and in improving body composition in adults with the condition [6]. These studies typically involve extensive trials to evaluate safety and effectiveness across different patient populations and age groups.
What Are the Potential Side Effects of Norditropin?
Like all medications, Norditropin can have side effects. Common side effects may include injection site reactions such as redness, itching, or swelling. Other potential side effects can include muscle or joint pain, fluid retention, and fatigue [7]. It is important for patients to discuss any concerns or experienced side effects with their healthcare provider.
Can Generic Versions of Norditropin Become Available?
The availability of generic versions of Norditropin depends on the expiry of its patents and any regulatory approvals required for biosimilar versions. Once patents expire and regulatory hurdles are cleared, other companies may seek to market generic or biosimilar somatropin products [5].
Sources:
[1] https://www.norditropin.com/
[2] https://www.webmd.com/drugs/2/204394/norditropin-injection-solution/details
[3] https://www.medicalnewstoday.com/articles/323676
[4] https://www.rxlist.com/consumernorditropinnordiflex/drugs-medication
[5] https://drugpatentwatch.com/
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197447/
[7] https://www.mayoclinic.org/drugs-supplements/somatropin-injection-route/side-effects/drug-20070907